MedTrace Logo

DMSO-PDT of BCC - A 6 Year Follow up

NCT00218829 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2017-03-14

No results posted yet for this study

Summary

The purpose of this study is to registrate long time clinical and histological treatment response of basal cell carcinoma (BCC) lesions treated with one or two procedures of dimethylsulfoxide supported 5-aminolaevulinic acid photodynamic therapy (DMSO-PDT).

Conditions

  • Carcinoma, Basal Cell

Sponsors & Collaborators

  • St. Olavs Hospital

    collaborator OTHER

  • Norwegian University of Science and Technology

    lead OTHER

Principal Investigators

  • Eidi Christensen, MD · St. Olav University Hospital, Trondheim

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1997-09-30
Primary Completion
2004-12-31
Completion
2004-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00218829 on ClinicalTrials.gov